178 related articles for article (PubMed ID: 32755207)
1. CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy.
Azar A; Garner HW; Rhodes NG; Yarlagadda B; Wessell DE
AJR Am J Roentgenol; 2021 Apr; 216(4):1022-1030. PubMed ID: 32755207
[No Abstract] [Full Text] [Related]
2. Distinguishing Untreated Osteoblastic Metastases From Enostoses Using CT Attenuation Measurements.
Ulano A; Bredella MA; Burke P; Chebib I; Simeone FJ; Huang AJ; Torriani M; Chang CY
AJR Am J Roentgenol; 2016 Aug; 207(2):362-8. PubMed ID: 27101076
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses.
Elangovan SM; Sebro R
AJR Am J Roentgenol; 2018 Mar; 210(3):615-620. PubMed ID: 29323547
[TBL] [Abstract][Full Text] [Related]
4. Optimized CT Attenuation and SUV Prediction Thresholds for Differentiating Enostoses From Untreated and Treated Metastases on Attenuation-Corrected 18F-FDG PET/CT.
Lee HT; Pryma DA; Sebro R
Clin Nucl Med; 2020 Jan; 45(1):32-37. PubMed ID: 31693615
[TBL] [Abstract][Full Text] [Related]
5. Paediatric bone lesions: diagnostic accuracy of imaging correlation and CT-guided needle biopsy for differentiating benign from malignant lesions.
Vidoni A; Pressney I; Saifuddin A
Br J Radiol; 2021 Apr; 94(1120):20201234. PubMed ID: 33565896
[TBL] [Abstract][Full Text] [Related]
6. Editorial Comment on "CT Attenuation Values Do Not Reliably Distinguish Benign Sclerotic Lesions From Osteoblastic Metastases in Patients Undergoing Bone Biopsy".
Bush CH
AJR Am J Roentgenol; 2021 Apr; 216(4):1030. PubMed ID: 32812793
[No Abstract] [Full Text] [Related]
7. Bone islands incidentally detected on computed tomography: frequency of enostosis and differentiation from untreated osteoblastic metastases based on CT attenuation value.
Sala F; Dapoto A; Morzenti C; Firetto MC; Valle C; Tomasoni A; Sironi S
Br J Radiol; 2019 Nov; 92(1103):20190249. PubMed ID: 31469323
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT.
Hong JH; Jung JY; Jo A; Nam Y; Pak S; Lee SY; Park H; Lee SE; Kim S
Radiology; 2021 Jun; 299(3):626-632. PubMed ID: 33787335
[TBL] [Abstract][Full Text] [Related]
9. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
[TBL] [Abstract][Full Text] [Related]
10. Salt-and-Pepper Noise Sign on Fat-Fraction Maps by Chemical-Shift-Encoded MRI: A Useful Sign to Differentiate Bone Islands From Osteoblastic Metastases-A Preliminary Study.
Jeon SW; Kwack KS; Yun JS; Gho SM; Park S
AJR Am J Roentgenol; 2020 May; 214(5):1139-1145. PubMed ID: 32069082
[No Abstract] [Full Text] [Related]
11. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
13. Assessment of suspected bone metastases. CT with and without clinical information compared to CT-guided bone biopsy.
Ciray I; Aström G; Sundström C; Hagberg H; Ahlström H
Acta Radiol; 1997 Sep; 38(5):890-5. PubMed ID: 9332251
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy.
Leffler SG; Chew FS
AJR Am J Roentgenol; 1999 May; 172(5):1389-92. PubMed ID: 10227522
[TBL] [Abstract][Full Text] [Related]
16. CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic outcomes.
Chang IJ; Ilaslan H; Sundaram M; Schils J; Subhas N
Skeletal Radiol; 2018 May; 47(5):661-669. PubMed ID: 29218391
[TBL] [Abstract][Full Text] [Related]
17. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Computed Tomography Monitoring of Pelvic Bones in Patients With Breast Cancer Using Automated Bone Subtraction Software.
Horger M; Thaiss WM; Wiesinger B; Ditt H; Fritz J; Nikolaou K; Kloth C
Invest Radiol; 2017 Feb; 52(2):288-294. PubMed ID: 28002240
[TBL] [Abstract][Full Text] [Related]
19. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous CT-guided bone biopsy: diagnosis of malignancy in lesions with initially indeterminate biopsy results and CT features associated with diagnostic or indeterminate results.
Hwang S; Lefkowitz RA; Landa J; Zheng J; Moskowitz CS; Maybody M; Hameed M; Panicek DM
AJR Am J Roentgenol; 2011 Dec; 197(6):1417-25. PubMed ID: 22109298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
